These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 28078851

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The function of MiR-21 expression differences and pathogenesis on familial and triple negative breast Cancer serum.
    Song N, Liang B, Wang D.
    Pak J Pharm Sci; 2016 Mar; 29(2 Suppl):679-84. PubMed ID: 27113307
    [Abstract] [Full Text] [Related]

  • 3. Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.
    Thakur S, Grover RK, Gupta S, Yadav AK, Das BC.
    PLoS One; 2016 Mar; 11(7):e0158946. PubMed ID: 27404381
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer.
    Zeng Z, Chen X, Zhu D, Luo Z, Yang M.
    Yonsei Med J; 2017 Jul; 58(4):697-702. PubMed ID: 28540980
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer.
    Xiao M, Lou C, Xiao H, Yang Y, Cai X, Li C, Jia S, Huang Y.
    Br J Surg; 2018 Jan; 105(1):75-85. PubMed ID: 29116653
    [Abstract] [Full Text] [Related]

  • 8. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
    Qattan A, Intabli H, Alkhayal W, Eltabache C, Tweigieri T, Amer SB.
    BMC Cancer; 2017 Nov 28; 17(1):799. PubMed ID: 29183284
    [Abstract] [Full Text] [Related]

  • 9. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
    Motawi TM, Sadik NA, Shaker OG, El Masry MR, Mohareb F.
    Gene; 2016 Sep 30; 590(2):210-9. PubMed ID: 26827795
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India.
    Sultana R, Kataki AC, Borthakur BB, Basumatary TK, Bose S.
    Gene; 2017 Jul 20; 621():51-58. PubMed ID: 28414093
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA, Huang WC, Lee WH, Wu A, Wang LS, Hsiao M, Yeh CT, Chao TY.
    BMC Cancer; 2016 Feb 25; 16():160. PubMed ID: 26917489
    [Abstract] [Full Text] [Related]

  • 16. Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.
    Cecene G, Ak S, Eskiler GG, Demirdogen E, Erturk E, Gokgoz S, Polatkan V, Egeli U, Tunca B, Tezcan G, Topal U, Tolunay S, Tasdelen I.
    Asian Pac J Cancer Prev; 2016 Feb 25; 17(9):4241-4246. PubMed ID: 27797225
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.